InvestorsHub Logo
Followers 42
Posts 5506
Boards Moderated 0
Alias Born 01/28/2010

Re: None

Tuesday, 06/01/2010 7:20:03 PM

Tuesday, June 01, 2010 7:20:03 PM

Post# of 18319
I'm new to this board. Does anyone know the status of HDVY's commercialization of their prostate cancer test? Are they close to launching their product? Does the product have a name?

Today (6/1) it was reported in the news that "A urine test can help doctors better spot prostate cancer than either the current blood test or a rectal exam alone, U.S. researchers reported on Tuesday."

They said Gen-Probe's Progensa PCA3 test caught about half the actual cases of prostate cancer in men who had abnormal PSA levels or digital rectal exams, and had about a 20 percent "false positive" rate.

http://www.reuters.com/article/idUSTRE6505ZS20100601

From what I have read about HDVY's test, their new gene-based molecular diagnostic test for prostate cancer achieved a Sensitivity of 90% for correctly identifying the presence of Grade 3 or higher prostate cancer cells, and a Specificity of 97% for correctly identifying non-cancer cells (normal and BPH), representing an overall test accuracy of 93.

In light of the much better results form HDVY why are we still hearing news about how "good" Gen-Probe's Progensa PCA3 test is?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HDVY News